Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease.

Adamus WS, Leonard JP, Tröger W.

Life Sci. 1995;56(11-12):883-90.

PMID:
10188789
2.

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, Egozi I, Sonego H, Marcovitch I, Brandeis R.

J Mol Neurosci. 2003;20(3):349-56. Review.

PMID:
14501019
3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
4.

Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists.

Mirza NR, Peters D, Sparks RG.

CNS Drug Rev. 2003 Summer;9(2):159-86. Review.

5.

M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.

Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, Pittel Z, Marciano D, Brandeis R, Sadot E, Barg Y, Pinkas-Kramarski R, Vogel Z, Ginzburg I, Treves TA, Verchovsky R, Klimowsky S, Korczyn AD.

Ann N Y Acad Sci. 1996 Jan 17;777:189-96. Review.

PMID:
8624083
6.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
7.

Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease.

Clader JW, Wang Y.

Curr Pharm Des. 2005;11(26):3353-61. Review.

PMID:
16250841
8.
9.
10.

Muscarinic M(1) agonists in the treatment of Alzheimer's disease.

Korczyn AD.

Expert Opin Investig Drugs. 2000 Oct;9(10):2259-67. Review.

PMID:
11060805
11.

Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.

Renner UD, Oertel R, Kirch W.

Ther Drug Monit. 2005 Oct;27(5):655-65. Review.

PMID:
16175141
12.

Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials.

McArthur RA, Gray J, Schreiber R.

Curr Opin Investig Drugs. 2010 Jul;11(7):740-60. Review.

PMID:
20571970
13.
Items per page

Supplemental Content

Support Center